PatternsRadar
Sign in

NECLIFENectar Lifesciences Limited

NSEASM Stage IBand 5%
9.81INR-0.17 (-1.70%)Close · 20 Nov 2026
14 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹191 CrMarket cap
—P/E (TTM)
77.0%Delivery

Filings & corporate actions

76 results filed
CSV
Next results · Q3 FY27
Expected 23 Jan 2027 – 14 Feb 2027
Estimate: filed 23–45 days after quarter end, last 5 times
Dividend
₹0.05 per share · last 11 Sept 2020
2026
  • 14 NovresultsResults · Q2 FY27 · consolidated and standalone-3.3%NSE
  • 14 OctshareholdingShareholding · 30 Sept 2026+0.1%NSE
  • 14 AugresultsResults · Q1 FY27 · consolidated and standalone+2.1%NSE
  • 13 JulshareholdingShareholding · 30 Jun 2026-0.9%NSE
  • 30 MayresultsResults · Q4 FY26 · consolidated and standalone-2.9%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026-0.9%NSE
  • 29 JanshareholdingShareholding · 20 Jan 2026-1.1%NSE
  • 23 JanresultsResults · Q3 FY26 · consolidated and standalone-4.6%NSE
  • 6 JanshareholdingShareholding · 31 Dec 2025+1.9%NSE

Reaction to results · all yearsrose on day 0 in 26 of 76 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2714 Nov 2026-3.3%——1.0×
Q1 FY2714 Aug 2026+2.1%-2.5%+3.6%2.0×
Q4 FY2630 May 2026-2.9%-6.5%-7.1%0.5×
Q3 FY2623 Jan 2026-4.6%-5.1%-13.4%0.6×
Q2 FY2614 Nov 2025-1.0%-4.3%+42.4%1.6×
Q1 FY2614 Aug 2025+4.1%+6.2%+17.0%0.5×
Q4 FY258 Jul 2025-20.0%-22.5%-36.1%20.8×
Q3 FY2531 Jan 2025+5.0%+11.9%-24.8%0.4×
Q2 FY2514 Nov 2024+2.0%-4.7%+17.6%11.0×
Q1 FY2514 Aug 2024-1.0%+20.7%+73.3%0.7×
Q4 FY2415 May 2024-4.3%-6.7%-7.1%1.1×
Q3 FY2414 Feb 2024+0.5%+13.0%-13.4%0.7×
Q2 FY2410 Nov 2023+7.1%+7.1%+20.9%16.2×
Q1 FY2414 Aug 2023+0.2%+3.2%+3.2%0.5×
Q4 FY2326 May 2023-1.7%+0.6%+9.0%1.0×
Q3 FY2314 Feb 2023-0.5%-7.0%-12.4%0.5×
Q2 FY2315 Nov 2022-3.3%-6.8%+9.1%2.2×
Q1 FY2313 Aug 2022-2.0%-7.3%+2.9%1.4×
Q4 FY2230 May 2022+3.1%-3.3%-8.9%1.4×
Q3 FY2214 Feb 2022+4.0%-9.0%-9.8%0.5×
Q2 FY2213 Nov 2021-1.9%-4.5%+5.0%0.9×
Q1 FY2214 Aug 2021-3.2%-6.1%-0.5%0.8×
Q4 FY2123 Jul 2021-4.5%-12.6%-27.4%0.8×
Q3 FY2113 Feb 2021-4.7%-2.9%0.0%2.6×
Q2 FY2130 Oct 2020-6.2%-15.7%+9.5%1.5×
Q1 FY211 Oct 2020-5.5%-3.4%-17.3%1.5×
Q4 FY2029 Jul 2020-9.8%-2.2%+4.9%1.7×
Q3 FY2011 Feb 2020-2.2%-5.6%-32.2%0.8×
Q2 FY2014 Nov 2019-14.4%-10.1%-17.4%3.0×
Q1 FY2014 Aug 2019-6.1%-16.0%-6.7%1.4×
Q4 FY1925 May 2019+19.8%+9.2%-11.5%32.6×
Q3 FY1919 Feb 2019+0.3%+3.1%+13.5%0.3×
Q2 FY1927 Nov 2018-1.0%-2.9%-3.6%0.7×
Q1 FY1920 Aug 2018-1.3%+21.2%+8.8%0.7×
Q4 FY1821 Jun 2018-2.4%-11.2%-22.3%0.5×
Q3 FY1814 Feb 2018-2.9%-5.9%-9.7%0.5×
Q2 FY1822 Nov 2017+7.5%+2.3%+15.7%3.8×
Q1 FY181 Sept 2017+5.9%+3.4%+0.9%1.6×
Q4 FY1727 Jun 2017-3.1%-0.2%-1.2%0.8×
Q3 FY1717 Feb 2017+1.8%-0.5%-3.0%1.6×
Q2 FY1716 Dec 2016-1.5%-8.5%-3.9%5.1×
Q1 FY1720 Sept 2016-2.1%+2.9%-5.6%0.6×
Q4 FY1630 May 2016-6.5%-10.4%-6.7%1.7×
Q3 FY169 Feb 2016-3.1%-13.3%-4.2%0.4×
Q2 FY1613 Nov 2015-4.9%+0.6%+5.7%0.5×
Q1 FY1614 Aug 2015-0.6%-5.9%-5.4%0.7×
Q4 FY1529 May 2015-0.9%-8.4%-6.5%0.5×
Q3 FY1518 Feb 2015-0.3%-17.0%+25.4%0.3×
Q2 FY1521 Nov 2014-4.2%-10.7%-20.0%0.5×
Q1 FY1518 Aug 2014+5.3%+43.0%+48.3%1.7×
Q4 FY1428 May 2014-1.1%+6.0%+4.8%0.6×
Q3 FY1411 Feb 2014-2.8%-7.4%+12.3%0.5×
Q2 FY1425 Nov 2013-0.6%+1.5%+4.4%0.4×
Q1 FY1417 Aug 2013-5.5%+2.7%+8.2%1.4×
Q4 FY1318 May 2013-4.5%-13.4%-9.2%1.1×
Q3 FY1319 Feb 2013+0.9%-1.5%+11.2%0.3×
Q2 FY131 Nov 2012+5.0%+14.4%+20.8%1.7×
Q1 FY1311 Aug 20120.0%+7.0%+23.3%0.2×
Q4 FY1214 May 2012-6.0%-11.4%-9.4%0.9×
Q3 FY1210 Feb 2012+9.3%+7.2%+2.8%4.6×
Q2 FY1212 Nov 2011-3.3%-8.1%-11.7%0.6×
Q1 FY1217 Aug 2011-0.5%-5.5%+3.0%1.4×
Q4 FY1112 May 2011+1.1%-9.9%-0.4%2.1×
Q3 FY1114 Jan 2011-4.6%-1.6%-13.0%1.8×
Q2 FY118 Nov 2010-4.1%-4.8%-23.1%1.9×
Q1 FY1111 Aug 2010-3.2%-1.1%+1.1%1.3×
Q3 FY1012 Jan 2010+2.3%+3.9%-7.3%7.6×
Q2 FY1020 Oct 2009+5.0%+9.9%+14.3%4.1×
Q1 FY1024 Jul 2009-0.5%+2.5%+4.9%1.1×
Q3 FY0931 Jan 2009-11.6%-14.5%-24.1%3.1×
Q2 FY0931 Oct 2008+20.0%+40.7%+13.0%1.6×
Q1 FY0928 Jul 2008-1.0%+5.5%+13.3%0.4×
Q3 FY0828 Jan 2008+2.6%+2.8%-7.2%0.7×
Q2 FY0830 Oct 2007+5.9%+0.8%+2.6%3.5×
Q1 FY0830 Jul 2007+4.4%+3.7%+4.8%0.7×
Q4 FY0730 Apr 2007+3.3%-7.1%-8.0%1.1×
Average-0.8%-1.2%+0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-99.8%
Profit YoY—
Interest cost YoY-32.2%
Revenue QoQ-24.1%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue-99.6%-97.4%-93.8%-88.8%-84.8%—
Profit——————

Key data

Open10.00
Day range9.55 – 10.19
52-week range9.30 – 22.40
From 52w high-56.2%
RSI (14)37.7
ATR (14)0.45
Volume1.73L
Avg volume (20D)1.00L
Rel volume1.73×
Volatility (1Y)50.1%
Turnover₹17.1L
Traded value (NSE)₹17.1L
VWAP9.84
SMA 50 / 20010.57 / 11.45
Price band5%

Delivery percentage

Latest · 20 Nov 202677.0%
20-day avg76.3%
1-year avg84.7%
Percentile (own history)86th
Range4.4–100.0%
Sessions3,629

Over the last 20 sessions NECLIFE settled 76.3% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 84.7%, so recent sessions are running 8.4 points lower than usual. The latest session ranks higher than 86% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders72.3K · -2.0% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy351 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.70%-7.97%-8.83%-4.66%-19.66%-33.49%

Valuation

Market cap₹191 Cr
Market cap (NSE)₹191 Cr
Free-float cap₹92 Cr
P/E (TTM)—
P/E (NSE)—
EPS (TTM)-3.41
P/B0.3
Net margin (TTM)-260110.6%
Other income / PBT—
ROE-10.3%
Debt / equity0.00
Shares outstanding19.43Cr
Listed18 Jul 2005

Ownership

Promoter51.84%
Promoter Δ QoQ0.00 pp
Public48.16%
FII0.50%
DII3.90%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)0.00.00.00.0
YoY chg-100.0%-100.0%-100.0%-99.8%
Net profit (₹ Cr)14.3(67.9)(15.4)2.7
YoY chg+82.0%———
Net margin——-106191.0%24763.6%
EPS0.64-3.38-0.790.14

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.84% · public 48.16%
30 Sept 2021: promoter 55.80%31 Dec 2021: promoter 55.80%31 Mar 2022: promoter 55.80%30 Jun 2022: promoter 55.80%30 Sept 2022: promoter 55.80%31 Dec 2022: promoter 55.80%31 Mar 2023: promoter 55.80%30 Jun 2023: promoter 55.80%30 Sept 2023: promoter 55.80%31 Dec 2023: promoter 55.80%31 Mar 2024: promoter 55.80%30 Jun 2024: promoter 55.80%30 Sept 2024: promoter 55.80%31 Dec 2024: promoter 44.53%31 Mar 2025: promoter 44.53%30 Jun 2025: promoter 44.53%30 Sept 2025: promoter 44.91%31 Dec 2025: promoter 44.91%20 Jan 2026: promoter 51.84%31 Mar 2026: promoter 51.84%30 Jun 2026: promoter 51.84%30 Sept 2026: promoter 51.84%
2021-092026-09
  • Promoter
  • Public and others
Promoter
51.84%
Public
48.16%
Promoter change
0.00 pp
Filed
14 Oct 2026
FII
0.50%
DII
3.90%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.50%

0.00 pp QoQ

Retail ≤ ₹2L
35.52%

-0.30 pp QoQ

HNI > ₹2L
2.10%

+0.34 pp QoQ

NRI
0.90%

-0.08 pp QoQ

Bodies corporate
3.03%

+0.09 pp QoQ

Shareholders
72,334

-2.0% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
SANJIV GOYALPromoter · Individual24.63%
SANJIV (HUF) - KARTA SANJIV GOYALPromoter · Individual22.46%
RAMAN GOYALPromoter · Individual4.76%
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDInstitution3.90%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 20 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2020-211₹0.05₹0.05
FY2019-201₹0.05₹0.05
FY2018-191₹0.05₹0.05
FY2017-181₹0.05₹0.05
FY2016-171₹0.10₹0.10
FY2015-161₹0.10₹0.10
FY2014-151₹0.10₹0.10
FY2013-141₹0.10₹0.10
FY2012-131₹0.10₹0.10
Ex-dateRecord dateDeclaredAdjusted
11 Sept 2020—₹0.05₹0.05
19 Sept 2019—₹0.05₹0.05
19 Sept 2018—₹0.05₹0.05
20 Sept 2017—₹0.05₹0.05
22 Sept 2016—₹0.10₹0.10
22 Sept 2015—₹0.10₹0.10
21 Aug 2014—₹0.10₹0.10
19 Sept 2013—₹0.10₹0.10
20 Sept 2012—₹0.10₹0.10

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
23 months ago
Disclosures on record
26
1 open-market of the newest 26
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
19 Dec 2024RAMAN GOYALPromoterBuy4.00L₹1.8Cr44.37— → 4.00L0.18%7(2)told 19 Dec 2024

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 4 Dec 2025

CSV
12 of 91 deals
By year
DateDealClientQuantityPriceValue
4 Dec 2025Sell · bulkJAIDEEP SAMPAT16.96L20.54₹3.5Cr
4 Dec 2025Buy · bulkMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED15.00L20.93₹3.1Cr
4 Dec 2025Buy · bulkRAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED15.00L20.87₹3.1Cr
4 Dec 2025Sell · bulkIRAGE BROKING SERVICES LLP14.79L20.47₹3.0Cr
4 Dec 2025Buy · bulkANKITA VISHAL SHAH13.50L21.01₹2.8Cr
4 Dec 2025Sell · bulkANKITA VISHAL SHAH13.50L20.65₹2.8Cr
4 Dec 2025Sell · bulkQE SECURITIES LLP12.67L20.36₹2.6Cr
4 Dec 2025Buy · bulkQE SECURITIES LLP11.80L20.60₹2.4Cr
4 Dec 2025Buy · bulkIRAGE BROKING SERVICES LLP8.00L20.48₹1.6Cr
11 Jul 2025Sell · bulkL7 HITECH PRIVATE LIMITED18.05L19.97₹3.6Cr
11 Jul 2025Sell · bulkSHARE INDIA SECURITIES LIMITED13.81L20.26₹2.8Cr
11 Jul 2025Buy · bulkSHARE INDIA SECURITIES LIMITED13.61L20.23₹2.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 28 Aug 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.

Price band: 5% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations452.2441.4359.3428.1455.0430.7280.75.00.00.00.00.0
Other income0.51.50.60.70.60.10.30.70.77.63.314.1
Total income452.7442.8359.9428.8455.6430.8281.05.70.77.63.414.1
Total expenses450.2431.7354.9420.1443.0618.4377.86.232.264.528.06.8
└ Finance costs24.824.220.019.817.117.718.70.030.25.90.2(0.0)
└ Depreciation15.414.715.515.515.615.816.50.20.10.10.10.1
Profit before tax2.511.14.98.712.5(187.7)(96.8)(0.5)56.6(56.9)(24.6)7.3
Tax expense0.910.51.93.14.7(57.6)(33.5)(0.2)(11.0)(19.7)(8.9)3.7
Net profit1.60.63.05.67.8(130.1)(63.2)(176.0)14.3(67.9)(15.4)2.7
EPS0.070.030.130.250.35-5.80-2.82-7.840.64-3.38-0.790.14
Net margin0.35%0.13%0.83%1.31%1.72%-30.20%-22.53%-3522.51%——-106191.03%24763.64%
PBT margin0.54%2.52%1.37%2.02%2.76%-43.57%-34.47%-10.13%——-169789.66%66109.09%
Tax rate36.21%94.67%39.62%35.39%37.52%———-19.48%——51.00%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 14 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets2,189.22,142.72,191.12,183.22,047.21,814.8621.6601.3
Current assets1,231.21,208.11,283.81,305.41,237.6259.0253.0235.3
└ Cash & equivalents17.620.019.818.219.25.90.0115.5
└ Other bank balances0.00.00.00.00.00.0112.10.0
└ Current investments0.30.30.50.50.50.513.055.5
└ Trade receivables279.6300.3379.2379.3345.554.30.00.0
└ Inventories672.6648.6709.2749.4690.23.00.30.0
Total equity1,064.61,067.41,069.21,077.8956.1716.9582.3569.6
└ Attributable to owners1,064.61,067.41,069.21,077.8956.1716.9582.3569.6
└ Non-controlling interest0.00.0—0.0————
└ Share capital22.422.422.422.422.422.419.419.4
Borrowings753.8681.3635.5629.1582.0458.80.00.0
└ Current527.4498.0495.2529.6521.9445.50.00.0
└ Non-current226.5183.3140.399.560.113.30.00.0
Trade payables318.8340.5419.7413.0438.12.30.00.0
Current liabilities890.9884.5972.8997.31,021.5712.726.120.2
Total liabilities1,124.61,075.31,121.81,105.41,091.11,097.939.331.7
Net debt735.9660.9615.2610.4562.3452.4(125.1)(171.1)
Debt / equity0.710.640.590.580.610.640.000.00
Current ratio1.381.371.321.311.210.369.7111.64

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow133.7115.9224.750.0169.4152.7(348.7)51.3
└ Capex(30.1)(13.8)(29.4)(6.6)(43.8)(8.9)(12.3)(1.2)
Free cash flow103.6102.1195.343.4125.6143.8(361.0)50.0
Investing cash flow51.7(2.8)(17.0)(5.3)(41.9)(8.2)1,208.1(47.7)
Financing cash flow(185.6)(110.7)(205.4)(46.2)(128.1)(157.7)(766.5)(0.2)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(0.2)2.52.2(1.6)(0.6)(13.3)92.93.4

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

NECLIFE at a glance

  • NECLIFE closed at ₹9.81 on 20 Nov 2026, -1.70% on the day, -33.5% over one year, 56.2% below its 52-week high of ₹22.4.
  • Delivery was 77.0% of traded quantity on 20 Nov 2026, the 86th percentile of its own 3,629 sessions with a reading (20-session average 76.3%, 1-year average 84.7%).
  • Market capitalisation is ₹191 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-3.41).
  • Q2 FY27 results (consolidated, filed 14 Nov 2026): revenue ₹0 crore (-99.8% year on year), net profit ₹3 crore; the price moved -3.3% on the first session after.
  • Promoters held 51.84% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 23 Jan 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE023H01027
SeriesEQ
Listed18 Jul 2005
NSE market cap · 17 Nov 2026₹199 Cr
Free-float market cap (NSE)₹88 Cr
Shares outstanding (NSE)19.43Cr
History from18 Jul 2005
Sessions5,288

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.